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A b s t r a c t  
The surface-enhanced Raman spectra (SERS) of neurotransmitters in biological 
matrices and synthetic solutions are described. The effects of protein adsorption on 
catecholamine SERS intensity are discussed. Techniques for obtaining dopamine SERS 
spectra in cerebrospinal fluid and rat brain dialysate are demonstrated. Preliminary 
SERS of histamine and tele-methylhistamine are presented. 
I n t r o d u c t i o n  
There axe about two hundred molecules which are known or suspected to func- 
tion as neurotransmitters .1-3 These include several aromatic amines, such as the cate- 
cholanfines, histamine and serotonin, several amino acids, and a large number of oligo- 
and polypeptides. In addition, neurobiologists ap.d pharmacologists have studied numer- 
ous closely related molecules, either as pharmaceuticals, or as probes of the important 
features of neurotransmitter alld receptor function and structure. 
Because the synaptic cleft in mammalian neurons is no more than 20 nm across, 
neither optical or physical probes of neurotransmitter concentrations in this region are 
practical. Instead, researchers have usually relied on probes placed in the extracellular 
fluid. 
Three general methods of real-time neurotransmitter measurement are flow perfu- 
sion, dialysis perfusion and voltammetry. 4 Flow perfusion techniques are based on the 
diffusion of materials into a stream of synthetic cerebrospinal fluid flowing into and out 
of the test area. The stream is pumped from a reservoir into a small tube (cannula) 
inserted into the test area of the brain or brain shce and removed by pmuping from a 
concentric cannula placed outside the input tube. The time constants are reasonably 
fast (10 sec), but materials are badly diluted by the flow process. Any convenient as- 
say technique can be used on the perfusate. Irmnunoassay, liquid chromatography with 
electrochemical or fluorescence detection and gas chromatography/mass spectrometry 
are among the common finishes. 
Dialysis perfusion techniques are based on transport of the neurotransmitter across 
a membrane which terminates a perfusion probe. The neurotransmitters are isolated 
and measured externally. Membranes with a molecular weight cutoff of 5,000 a.m.u. 
and lower have been used. s,° Dialysis perfusion is attractive because the protein burden 
of the sample is greatly reduced. In addition, dialysis decreases the extent of tissue 
damage at the probe site because the tissue is not directly exposed to fluid flow. The 
assay techniques are the same as those used in push-pull perfusion. 
Measurements of catecholamines, serotonin and their metabolites can be made by 
anodic voltammetry at a carbon electrode. 4,7 Voltammetry provides close to real-time 
response. Carbon electrodes range in size from 40-50 ~m diameter graphite epoxy disks 7 
to 1 ~m diameter carbon fibers s. Response times are a few seconds. 9 
Voltammetry is not problem free. It can be used only with catecholamines and sero- 
tonin, and some of their metabohtes, precursors or synthetic analogs. Further, the range 
of oxidation potentials within a class of molecules is small. In general, a neurotransmit- 
ter and its metabohtes or precursors can not be completely resolved v01tammetrically ~. 
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In addition, ascorbic acid is more easily oxidized than catecholamines or serotonin. 
On untreated carbon electrodes, an ascorbate signal badly overlaps catecholamine sig- 
nals. The problem can be overcome in several ways. Two effective methods are the 
use of chemically treated carbon paste electrodes 10 and use of Nation coated graphite 
electrodes. 11 
Histamine presents a special analytical challenge. It is not electroactive and it ab- 
sorbs deep in the UV, A , ~  = 207 nm, making LC detection difficult without derivati- 
zation. Radioenzymatic assay remains the commonly used finish to histamine perfusion 
studies. Histamine assays are notoriously difficult. Problems arise in part from the 
assay itself and in part from the variability in histamine content with the method used 
to sacrifice the test animal. 12 
T h e o r y  
Surface enhancement of Raman spectra occurs as the result of several processes 
which take place on structured metal surfaces la. These can be divided into two classes: 
electromagnetic effects 14,1s and chemical (or charge transfer) effects. 16 Since chemical 
enhancement is normally accompanied by electromagnetic enhancement, the total e~- 
hancement is the product of both processes. In this case, good spectra can be observed 
from molecules adsorbed from 10-6M solutions. Detection limits are for adsorption 
from solutions 10 -7 to 10-SM. 
Biogenic amine neurotransmitters such as dopamine, histamine and serotonhl are 
nearly ideal SERS substrates. As aromatic amines, they form strong complexes with 
silver, copper or gold. Charge transfer enhancement contributes to good SERS sensi- 
tivity. Each neurotransmitter can be viewed as an aromatic ring system with different 
substituents defining the neurotransmitter and its metabolites. Distinguishing among 
such compounds is a classic strength of vibrational spectroscopy. 
Hsieh et al. 17 have recently reported the SEllS spectra of the naturally-occttring 
catecholamines and some metabolites and analogs on silver electrodes. They demon- 
strated that the major bands in the spectra were aromatic ring modes due to the catechol 
moiety. Table I summarizes band positions and assignments in that system. 
Table  L 
SEllS shifts (cm -1) of catecholamines and related compounds. 
bands DA" NOR" MTA" catechol 
vls 1152 1150 
P c _  o 1269 1272 
v3 1331 1329 
v19. 1424 1422 












aAbbreviations: DA, dopamine; NOR, norepinephrine; MTA 3-methoxytyramine. 
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The intense band near 1480cm -1 has been assigned 17 to the benzene vlgb mode. 
This band is generally the most conveuient for quantitative measurements. Its absence 
distinguishes the methoxylated compom~ds from the catechol compounds. The band 
near 1270 cm -1 is the phenulic C-O stretch. It may also be used for quantification. 
Although the band positions in dopamine and norepinephrine are quite similar, the 
relative intensities are not. For example, v3 is strong in dopamine spectra, but quite 
weak in norepinephrine spectra. Thus, band intensity ratios can be used to distinguish 
dopamine from norepinephrine. 
Catecholamines with highly substituted ethylamine side chains give weak spectra. 
Bulky substituents apparently force an unfavorable adsorbate orientation. Spectra of 
anionic (acetate) metabolites have not been observed. For strong catecholamine ad- 
sorption, the electrode potential must be near the potential of zero charge. Under these 
conditions, anions are desorbed from the electrode surface. 
Hsieh et al. 17 worked only in synthetic electrolyte solutions. In the brain, how- 
ever, the extracellular fluid (ECF) contains electrolytes as well as small amounts of 
serum albumin, immmmglobins and other proteins. Cerebrospinal fluid is essentially 
the equivalent of the brain ECF. Other neurochemical samples, such as extracts of tis- 
sue homogenates, contain high protein burdens as well as lipids and other surface-active 
molecules. Because these surfactants could interfere with SERS measurements, it is 
important to investigate neurotransmitter SERS in these media. 
Ca techolamines  in Neurochemlca l  Media  
We present catecholamine SERS obtained in several neurochemical media using 
silver electrodes. The experimental apparatus and procedures were generally similar 
to those described by Hsieh et al. 17 The silver electrode was maintained at -0.9 V vs. 
S.C.E. For all experiments, a Spex Triplemate spectrograph equipped with a Tracor 
Northern or a PARC 1420 intensified diode array detector was employed. Integration 
times of 100 sec were used. Spectra were obtained using 30 mW of Ar + 514.5 nm 
excitation. Sample volumes were 0.2-0.5 ml. 
We have investigated the effects of protein adsorption on catecholamine SERS inten- 
sity. For this work, we have used albumin, which is the major protein in cerebrospinal 
fluid. Figure 1 shows the effect of albumin addition on dopamine SERS intensity. At 
0.5% albumin concentration, SERS intensity is reduced to roughly half its value in 
protein-free solutions, and there is a clear decrease in the quality of the spectrum. 
When the protein burden reaches 1%, the spectrum is barely visible. 
Figure 2 shows the SERS spectrum of cerebrospinal fluid (CSF, Sigma Diagnostics) 
spiked with approximately 2 x 10-SM dopamine. This concentration is near the upper 
end of the useful range for neurochemistry. The four major bands of the dopamine 
SERS spectrum are present but the signal magnitude and signal/noise ratio are slightly 
less than in the simple electrolyte solutions used by I-Isieh et.al,  l z  
In general, CSF has a protein concentration of between 15 and 40 mg per 100ml. is 
The assay value for the sample used here is 31 mg/100ml (0.31%). About 65% of the 
protein is serum albumin. CSF is viscous and the protein surfactants can cause extensive 
foaming. Consequently, CSF requires more careful handling than synthetic electrolyte 
solutions which contain only small molecules or ions. Standard addition may be used 
for quantification. However, the addition must be followed by thorough stirring to avoid 
artifacts. The Sigma CSF samples also contain 0.05% sodium azide as a preservative. 
The effects of azide, if any, are not yet known. 
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Figure 1. Effects of Albumin Concentration on Catecholamine SERS 
Intensity at pH 7. 
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J 
| . . . 
1200 1400 1600 
Flmnmn 5hilt, cm-1 
Figure 2. SERS Spectrum of Cerebrospinal Fluid, Spiked with 2 x 10-SM 
Dopamine. 
Figure 3 shows the spectrum of a dialysate sample obtained f~om a rat brain s ~ -  
tuna by Professors Jill Becket and Terry Robinson (University of Michigan, Departn~t 
. . . . . .  - . : , j  
of Psychology). The sample zs spiked wzth 5 x 10-aM dopamme. Wzth zts low residual 
protein content, the dialysate sample is nearly the equivalent of a synthetic electrolyte 
matrix. The signal magnitude and signal/noise ratio approach those obtained with 
simple aqueous solutions. 
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Figure 4. SERS Spectra of Histamine and tele-Methlyhistamlne at pH 7. 
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Histamine 
We have also made preliminary SERS measurements of histamine and its primary 
metabolite tele-methyl histamine on a silver electrode. As shown in Figure 4, the 
spectra of histamine and its metabolite are readily distinguished. In particular, the 
intense histamine bands at 1266, 1302 and 1312 cm -1 are missing in the methylated 
compound, which has the single strong 1332 cm -1 band in this region. The signal 
magnitudes and signal/noise ratios obtained in these spectra are similar to those of the 
catecholamines. 
Conclusions 
We are actively developing SEKS as a multi-purpose probe of neurotransmitter con- 
centrations. We have verified the feasibility of catecholamine SERS analysis of real bio- 
logical matrices and have demonstrated useful SERS from histamine and its methylated 
metabolite. We are developing new techniques to minimize protein interference. Very 
preliminary results with Nation-coated electrodes suggest that excellent catecholamine 
SERS can be obtained from coated electrodes. This technique may prove the key to 
practical SERS measurements in a variety of neurcchemJcal matrices. 
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